[1m[31mPubmed ID: 32703911[0m

Title: Can Dietary Fatty Acids Affect the COVID-19 Infection Outcome in Vulnerable Populations?

Authors: HÃ¤ggblom M M; Onishi J C; Shapses S A

Journal: mBio (mBio)

Date: 2020-07

Abstrct_EN: There is high mortality in coronavirus disease 2019 (COVID-19)-infected individuals with chronic inflammatory diseases, like obesity, diabetes, and hypertension. A cytokine storm in some patients after infection contributes to this mortality. In addition to lungs, the intestine is targeted during COVID-19 infection. The intestinal membrane serves as a barrier to prevent leakage of microorganisms and their products into the bloodstream; however, dietary fats can affect the gut microbiome and may increase intestinal permeability. In obese or diabetic individuals, there is an increase in the abundance of either Gram-negative bacteria in the gut or their product, endotoxin, in systemic circulation. We speculate that when the COVID-19 infection localizes in the intestine and when the permeability properties of the intestinal membrane are compromised, an inflammatory response is generated when proinflammatory endotoxin, produced by resident Gram-negative bacteria, leaks into the systemic circulation. This review discusses conditions contributing to inflammation that are triggered by microbially derived factors from the gut.

Abstrct_CN: å† çŠ¶ç—…æ¯’ç–¾ç—…2019ï¼ˆCOVID-19ï¼‰æ„ŸæŸ“çš„æ…¢æ€§ç‚ç—‡æ€§ç–¾ç—…ï¼ˆå¦‚è‚¥èƒ–ç—‡ï¼Œç³–å°¿ç—…å’Œé«˜è¡€å‹ï¼‰çš„æ­»äº¡ç‡å¾ˆé«˜ã€‚æ„ŸæŸ“åæŸäº›æ‚£è€…çš„ç»†èƒå› å­é£æš´å¯å¯¼è‡´è¿™ç§æ­»äº¡ã€‚é™¤è‚ºå¤–ï¼Œåœ¨COVID-19æ„ŸæŸ“æœŸé—´è¿˜ä»¥è‚ é“ä¸ºç›®æ ‡ã€‚è‚ è†œæ˜¯é˜²æ­¢å¾®ç”Ÿç‰©åŠå…¶äº§ç‰©æ¸—å…¥è¡€æ¶²çš„å±éšœã€‚ç„¶è€Œï¼Œè†³é£Ÿè„‚è‚ªä¼šå½±å“è‚ é“å¾®ç”Ÿç‰©ç»„ï¼Œå¹¶å¯èƒ½å¢åŠ è‚ é“é€šé€æ€§ã€‚åœ¨è‚¥èƒ–æˆ–ç³–å°¿ç—…ä¸ªä½“ä¸­ï¼Œè‚ é“ä¸­é©å…°æ°é˜´æ€§ç»†èŒæˆ–å…¶äº§ç‰©å†…æ¯’ç´ åœ¨ç³»ç»Ÿå¾ªç¯ä¸­çš„ä¸°åº¦å¢åŠ ã€‚æˆ‘ä»¬æ¨æµ‹ï¼Œå½“COVID-19æ„ŸæŸ“ä½äºè‚ é“å†…ï¼Œå¹¶ä¸”å½“è‚ è†œçš„é€šé€æ€§å—åˆ°æŸå®³æ—¶ï¼Œå½“é©»ç•™çš„é©å…°æ°é˜´æ€§ç»†èŒäº§ç”Ÿçš„ä¿ƒç‚æ€§å†…æ¯’ç´ æ³„æ¼åˆ°ä½“å¾ªç¯ä¸­æ—¶ï¼Œå°±ä¼šäº§ç”Ÿç‚ç—‡ååº”ã€‚è¿™ç¯‡ç»¼è¿°è®¨è®ºäº†ç”±è‚ é“ä¸­å¾®ç”Ÿç‰©è¡ç”Ÿçš„å› ç´ è§¦å‘çš„ä¿ƒå‘ç‚ç—‡çš„ç–¾ç—…ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32709258[0m

Title: Catabolism and interactions of uncultured organisms shaped by eco-thermodynamics in methanogenic bioprocesses.

Authors: Kamagata Yoichi; Lee Patrick K H; Lee Po-Heng; Liu Wen-Tso; McInerney Michael J; Mei Ran; Narihiro Takashi; Nobu Masaru K

Journal: Microbiome (Microbiome)

Date: 2020-Jul

Abstrct_EN: Current understanding of the carbon cycle in methanogenic environments involves trophic interactions such as interspecies H<sub>2</sub> transfer between organotrophs and methanogens. However, many metabolic processes are thermodynamically sensitive to H<sub>2</sub> accumulation and can be inhibited by H<sub>2</sub> produced from co-occurring metabolisms. Strategies for driving thermodynamically competing metabolisms in methanogenic environments remain unexplored. To uncover how anaerobes combat this H<sub>2</sub> conflict in situ, we employ metagenomics and metatranscriptomics to revisit a model ecosystem that has inspired many foundational discoveries in anaerobic ecology-methanogenic bioreactors. Through analysis of 17 anaerobic digesters, we recovered 1343 high-quality metagenome-assembled genomes and corresponding gene expression profiles for uncultured lineages spanning 66 phyla and reconstructed their metabolic capacities. We discovered that diverse uncultured populations can drive H<sub>2</sub>-sensitive metabolisms through (i) metabolic coupling with concurrent H<sub>2</sub>-tolerant catabolism, (ii) forgoing H<sub>2</sub> generation in favor of interspecies transfer of formate and electrons (cytochrome- and pili-mediated) to avoid thermodynamic conflict, and (iii) integration of low-concentration O<sub>2</sub> metabolism as an ancillary thermodynamics-enhancing electron sink. Archaeal populations support these processes through unique methanogenic metabolisms-highly favorable H<sub>2</sub> oxidation driven by methyl-reducing methanogenesis and tripartite uptake of formate, electrons, and acetate. Integration of omics and eco-thermodynamics revealed overlooked behavior and interactions of uncultured organisms, including coupling favorable and unfavorable metabolisms, shifting from H<sub>2</sub> to formate transfer, respiring low-concentration O<sub>2</sub>, performing direct interspecies electron transfer, and interacting with high H<sub>2</sub>-affinity methanogenesis. These findings shed light on how microorganisms overcome aÂ critical obstacle in methanogenic carbon cycles we had hitherto disregardedÂ and provide foundationalÂ insight into anaerobic microbialÂ ecology. Video Abstract.

Abstrct_CN: ç›®å‰å¯¹äº§ç”²çƒ·ç¯å¢ƒä¸­ç¢³å¾ªç¯çš„è®¤è¯†æ¶‰åŠè¥å…»ç›¸äº’ä½œç”¨ï¼Œä¾‹å¦‚æœ‰æœºè¥å…»ç‰©å’Œäº§ç”²çƒ·èŒä¹‹é—´çš„ç§é—´H <sub> 2 </ sub>è½¬ç§»ã€‚ç„¶è€Œï¼Œè®¸å¤šä»£è°¢è¿‡ç¨‹å¯¹H <sub> 2 </ sub>çš„ç§¯ç´¯æ˜¯çƒ­åŠ›å­¦æ•æ„Ÿçš„ï¼Œå¹¶ä¸”å¯ä»¥è¢«å…±ç”Ÿä»£è°¢äº§ç”Ÿçš„H <sub> 2 </ sub>æŠ‘åˆ¶ã€‚åœ¨äº§ç”²çƒ·ç¯å¢ƒä¸­é©±åŠ¨çƒ­åŠ›å­¦ç«äº‰æ€§ä»£è°¢çš„ç­–ç•¥å°šæœªæ¢ç´¢ã€‚ä¸ºäº†æ­ç¤ºåŒæ°§èŒå¦‚ä½•åŸä½å¯¹æŠ—H <sub> 2 </ sub>å†²çªï¼Œæˆ‘ä»¬é‡‡ç”¨å®åŸºå› ç»„å­¦å’Œè¶…è½¬å½•ç»„å­¦é‡æ–°å®¡è§†äº†ä¸€ä¸ªæ¨¡å‹ç”Ÿæ€ç³»ç»Ÿï¼Œè¯¥æ¨¡å‹ç”Ÿæ€ç³»ç»Ÿå¯å‘äº†åŒæ°§ç”Ÿæ€å­¦-ç”²çƒ·ç”Ÿç‰©ååº”å™¨ä¸­çš„è®¸å¤šåŸºç¡€å‘ç°ã€‚é€šè¿‡å¯¹17ä¸ªåŒæ°§æ¶ˆåŒ–æ± çš„åˆ†æï¼Œæˆ‘ä»¬ä¸ºè·¨è¶Š66ä¸ªé—¨çš„æœªåŸ¹å…»è°±ç³»æ¢å¤äº†1343ä¸ªé«˜è´¨é‡çš„å…ƒåŸºå› ç»„ç»„è£…åŸºå› ç»„å’Œç›¸åº”çš„åŸºå› è¡¨è¾¾è°±ï¼Œå¹¶é‡å»ºäº†å®ƒä»¬çš„ä»£è°¢èƒ½åŠ›ã€‚æˆ‘ä»¬å‘ç°ï¼Œä¸åŒçš„æœªåŸ¹å…»ç§ç¾¤å¯ä»¥é€šè¿‡ï¼ˆiï¼‰ä»£è°¢è€¦åˆä¸åŒæ—¶å‘ç”Ÿçš„H <sub> 2 </ sub>è€å—çš„åˆ†è§£ä»£è°¢æ¥é©±åŠ¨H <sub> 2 </ sub>æ•æ„Ÿçš„ä»£è°¢ï¼Œï¼ˆiiï¼‰æ”¾å¼ƒH <sub> 2 </ sub>çš„äº§ç”Ÿæœ‰åˆ©äºç”²é…¸å’Œç”µå­ä¹‹é—´çš„ç§é—´è½¬ç§»ï¼ˆç»†èƒè‰²ç´ å’ŒèŒæ¯›ä»‹å¯¼ï¼‰ï¼Œä»¥é¿å…çƒ­åŠ›å­¦å†²çªï¼Œä»¥åŠï¼ˆiiiï¼‰å°†ä½æµ“åº¦O <sub> 2 </ sub>ä»£è°¢æ•´åˆä¸ºè¾…åŠ©çƒ­åŠ›å­¦å¢å¼ºç”µå­æ¥æ”¶å™¨ã€‚å¤ç»†èŒç§ç¾¤é€šè¿‡ç‹¬ç‰¹çš„äº§ç”²çƒ·ä»£è°¢æ”¯æŒè¿™äº›è¿‡ç¨‹-é«˜åº¦æœ‰åˆ©çš„H <sub> 2 </ sub>æ°§åŒ–ï¼Œç”±ç”²åŸºè¿˜åŸç”²çƒ·ç”Ÿæˆå’Œç”²é…¸é…¯ï¼Œç”µå­å’Œä¹™é…¸çš„ä¸‰æ–¹å¸æ”¶é©±åŠ¨ã€‚ç»„å­¦å’Œç”Ÿæ€çƒ­åŠ›å­¦çš„æ•´åˆæ­ç¤ºäº†æœªåŸ¹å…»ç”Ÿç‰©çš„è¡Œä¸ºå’Œç›¸äº’ä½œç”¨è¢«å¿½ç•¥äº†ï¼ŒåŒ…æ‹¬è‰¯å¥½å’Œä¸åˆ©çš„æ–°é™ˆä»£è°¢è€¦åˆï¼Œä»H <sub> 2 </ sub>è½¬ç§»åˆ°ç”²é…¸è½¬ç§»ï¼Œå‘¼å¸ä½æµ“åº¦O <sub> 2 </ sub >ï¼Œè¿›è¡Œç›´æ¥çš„ç§é—´ç”µå­è½¬ç§»ï¼Œå¹¶ä¸é«˜H <sub> 2 </ sub>äº²å’Œæ€§ç”²çƒ·åŒ–ç›¸äº’ä½œç”¨ã€‚è¿™äº›å‘ç°æ­ç¤ºäº†å¾®ç”Ÿç‰©å¦‚ä½•å…‹æœè¿„ä»Šä¸ºæ­¢æˆ‘ä»¬æ‰€å¿½ç•¥çš„äº§ç”²çƒ·ç¢³å¾ªç¯ä¸­çš„å…³é”®éšœç¢ï¼Œå¹¶ä¸ºåŒæ°§å¾®ç”Ÿç‰©ç”Ÿæ€å­¦æä¾›äº†åŸºç¡€çŸ¥è¯†ã€‚å½•åƒæ‘˜è¦ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32709975[0m

Title: Termite mounds contain soil-derived methanotroph communities kinetically adapted to elevated methane concentrations.

Authors: Arndt Stefan K; Chiri Eleonora; Dong Xiyang; Greening Chris; Jirapanjawat Thanavit; Lappan Rachael; Nauer Philipp A; Waite David W

Journal: The ISME journal (ISME J)

Date: 2020-Jul

Abstrct_EN: Termite mounds have recently been confirmed to mitigate approximately half of termite methane (CH<sub>4</sub>) emissions, but the aerobic CH<sub>4</sub> oxidising bacteria (methanotrophs) responsible for this consumption have not been resolved. Here, we describe the abundance, composition and CH<sub>4</sub> oxidation kinetics of the methanotroph communities in the mounds of three distinct termite species sampled from Northern Australia. Results from three independent methods employed show that methanotrophs are rare members of microbial communities in termite mounds, with a comparable abundance but distinct composition to those of adjoining soil samples. Across all mounds, the most abundant and prevalent methane monooxygenase sequences were affiliated with upland soil cluster Î± (USCÎ±), with sequences homologous to Methylocystis and tropical upland soil cluster (TUSC) also detected. The reconstruction of a metagenome-assembled genome of a mound USCÎ± representative highlighted the metabolic capabilities of this group of methanotrophs. The apparent Michaelis-Menten kinetics of CH<sub>4</sub> oxidation in mounds were estimated from in situ reaction rates. Methane affinities of the communities were in the low micromolar range, which is one to two orders of magnitude higher than those of upland soils, but significantly lower than those measured in soils with a large CH<sub>4</sub> source such as landfill cover soils. The rate constant of CH<sub>4</sub> oxidation, as well as the porosity of the mound material, were significantly positively correlated with the abundance of methanotroph communities of termite mounds. We conclude that termite-derived CH<sub>4</sub> emissions have selected for distinct methanotroph communities that are kinetically adapted to elevated CH<sub>4</sub> concentrations. However, factors other than substrate concentration appear to limit methanotroph abundance and hence these bacteria only partially mitigate termite-derived CH<sub>4</sub> emissions. Our results also highlight the predominant role of USCÎ± in an environment with elevated CH<sub>4</sub> concentrations and suggest a higher functional diversity within this group than previously recognised.

Abstrct_CN: æœ€è¿‘å·²ç¡®è®¤ç™½èšä¸˜å¯ä»¥å‡è½»å¤§çº¦ä¸€åŠçš„ç™½èšç”²çƒ·ï¼ˆCH <sub> 4 </ sub>ï¼‰æ’æ”¾ï¼Œä½†æ˜¯å°šæœªå¼•èµ·è¿™ç§æ¶ˆè€—çš„å¥½æ°§CH <sub> 4 </ sub>æ°§åŒ–ç»†èŒï¼ˆç”²çƒ·ï¼‰ã€‚è§£å†³ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬æè¿°äº†ä»åŒ—æ¾³å¤§åˆ©äºšé‡‡æ ·çš„ä¸‰ç§ä¸åŒç™½èšç‰©ç§çš„åœŸå †ä¸­ç”²çƒ·è¥å…»èŒç¾¤è½çš„ä¸°åº¦ï¼Œç»„æˆå’ŒCH <sub> 4 </ sub>æ°§åŒ–åŠ¨åŠ›å­¦ã€‚ä¸‰ç§ç‹¬ç«‹æ–¹æ³•çš„ç»“æœè¡¨æ˜ï¼Œç”²çƒ·è¥å…»èŒæ˜¯ç™½èšä¸˜ä¸­å¾®ç”Ÿç‰©ç¾¤è½çš„ç¨€æœ‰æˆå‘˜ï¼Œå…¶ä¸°åº¦å¯æ¯”ä½†ä¸ç›¸é‚»åœŸå£¤æ ·å“çš„å¾®ç”Ÿç‰©ç»„æˆæˆªç„¶ä¸åŒã€‚åœ¨æ‰€æœ‰åœŸä¸˜ä¸­ï¼Œæœ€ä¸°å¯Œï¼Œæœ€æ™®éçš„ç”²çƒ·å•åŠ æ°§é…¶åºåˆ—ä¸å±±åœ°åœŸå£¤ç°‡Î±ï¼ˆUSCÎ±ï¼‰ç›¸å…³ï¼Œå¹¶ä¸”ä¸ç”²åŸºå›Šè—»å’Œçƒ­å¸¦å±±åœ°åœŸå£¤ç°‡ï¼ˆTUSCï¼‰åŒæºã€‚åœŸå¢©USCÎ±ä»£è¡¨çš„åŸºå› ç»„ç»„è£…åŸºå› ç»„çš„é‡å»ºçªæ˜¾äº†è¿™ä¸€ç»„ç”²çƒ·è¥å…»ç”Ÿç‰©çš„ä»£è°¢èƒ½åŠ›ã€‚æ ¹æ®åŸä½ååº”é€Ÿç‡ä¼°ç®—äº†CH <sub> 4 </ sub>åœ¨åœŸå †ä¸­çš„è¡¨è§‚Michaelis-MentenåŠ¨åŠ›å­¦ã€‚ç¾¤è½çš„ç”²çƒ·äº²å’ŒåŠ›å¤„äºè¾ƒä½çš„å¾®æ‘©å°”èŒƒå›´ï¼Œæ¯”é™†åœ°åœŸå£¤çš„ç”²çƒ·äº²å’ŒåŠ›é«˜ä¸€åˆ°ä¸¤ä¸ªæ•°é‡çº§ï¼Œä½†æ˜¾ç€ä½äºCH <sub> 4 </ sub>æ¥æºè¾ƒå¤§çš„åœŸå£¤ä¸­çš„ç”²çƒ·äº²å’ŒåŠ›ã€‚åƒåœ¾å¡«åŸ‹åœºè¦†ç›–åœŸå£¤ã€‚ CH <sub> 4 </ sub>çš„æ°§åŒ–é€Ÿç‡å¸¸æ•°ä»¥åŠåœŸå †ææ–™çš„å­”éš™ç‡ä¸ç™½èšåœŸä½“ç”²çƒ·è¥å…»èŒç¾¤è½çš„ä¸°å¯Œç¨‹åº¦å‘ˆæ˜¾ç€æ­£ç›¸å…³ã€‚æˆ‘ä»¬å¾—å‡ºçš„ç»“è®ºæ˜¯ï¼Œç™½èšè¡ç”Ÿçš„CH <sub> 4 </ sub>æ’æ”¾ç‰©å·²è¢«é€‰æ‹©ç”¨äºä¸åŒçš„ç”²çƒ·è¥å…»ç”Ÿç‰©ç¾¤è½ï¼Œè¿™äº›ç¾¤è½åœ¨åŠ¨åŠ›å­¦ä¸Šé€‚åº”äºå‡é«˜çš„CH <sub> 4 </ sub>æµ“åº¦ã€‚ç„¶è€Œï¼Œé™¤åº•ç‰©æµ“åº¦å¤–ï¼Œå…¶ä»–å› ç´ ä¼¼ä¹ä¹Ÿé™åˆ¶äº†ç”²çƒ·æ°§åŒ–èŒçš„ä¸°åº¦ï¼Œå› æ­¤è¿™äº›ç»†èŒåªèƒ½éƒ¨åˆ†å‡è½»ç™½èšè¡ç”Ÿçš„CH <sub> 4 </ sub>çš„æ’æ”¾ã€‚æˆ‘ä»¬çš„ç ”ç©¶ç»“æœè¿˜çªå‡ºæ˜¾ç¤ºäº†USCÎ±åœ¨CH <sub> 4 </ sub>æµ“åº¦å‡é«˜çš„ç¯å¢ƒä¸­çš„ä¸»è¦ä½œç”¨ï¼Œå¹¶è¡¨æ˜è¯¥ç»„ä¸­çš„åŠŸèƒ½å¤šæ ·æ€§æ¯”ä»¥å‰å…¬è®¤çš„æ›´é«˜ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32730093[0m

Title: Augmented Lipocalin-2 is Associated with COPD and Counteracts Lung Adenocarcinoma Development.

Authors: Behrens Carmen; Cascone Tina; Chang Kyle; Deng Shanshan; Fujimoto Junya; Fukuoka Junya; Hara Kieko; Hassane Maya; Kadara Humam; Kantrowitz Jacob; Lang Wenhua; Lu Wei; McAllister Florencia; McDowell Tina L; Moghaddam Seyed Javad; Nunomura-Nakamura Sayuri; Ochieng Joshua K; Ostrin Edwin J; Parra Edwin; Rahal Zahraa; Raso Maria Gabriela; Reuben Alexandre; Scheet Paul A; Sinjab Ansam; Sivakumar Smruthy; Solis Luisa M; Spira Avrum E; Treekitkarnmongkol Warapen; Wistuba Ignacio I; Xu Li; Zhang Jiexin; Zhou Jianling

Journal: American journal of respiratory and critical care medicine (Am. J. Respir. Crit. Care Med.)

Date: 2020-Jul

Abstrct_EN: <b>Rationale:</b> Early pathogenesis of lung adenocarcinoma (LUAD) remains largely unknown. We found that, relative to wild-type littermates, the innate immunomodulator lipocalin-2 (<i>Lcn2</i>) was increased in normal airways from mice with knockout of the airway lineage gene <i>Gprc5a</i> (<i>Gprc5a<sup>-/-</sup></i>), and that are prone to developing inflammation and LUAD. Yet, the role of LCN2 in lung inflammation and LUAD is poorly understood. <b>Objectives:</b> Delineate the role of <i>Lcn2</i> induction in LUAD pathogenesis. <b>Methods:</b> Normal airway brushings, uninvolved lung tissues and tumors from <i>Gprc5a<sup>-/-</sup></i> mice prior to and following tobacco carcinogen exposure were analyzed by RNA-sequencing. <i>LCN2</i> mRNA was analyzed in public and in-house datasets of LUAD, lung squamous cancer (LUSC), chronic obstructive pulmonary disease (COPD) and LUAD/LUSC with COPD. LCN2 protein was immunohistochemically analyzed in a tissue microarray of 510 tumors. Temporal lung tumor development, gene expression programs and host immune responses were compared between <i>Gprc5a<sup>-/-</sup></i> and <i>Gprc5a<sup>-/-</sup>/Lcn2<sup>-/-</sup></i> littermates. <b>Measurements and Main Results:</b><i>Lcn2</i> was progressively elevated during LUAD development and positively correlated with pro-inflammatory cytokines and inflammation gene sets. <i>LCN2</i> was distinctively elevated in human LUADs, but not in LUSCs, relative to normal lungs and was associated with COPD among smokers and LUAD patients. Relative to <i>Gprc5a<sup>-/-</sup></i> mice, <i>Gprc5a<sup>-/-</sup>/Lcn2<sup>-/-</sup></i> littermates exhibited significantly increased lung tumor development concomitant with reduced T cell abundance (CD4+) and richness, attenuated anti-tumor immune gene programs and increased immune cell expression of pro-tumor inflammatory cytokines. <b>Conclusions:</b> Augmented LCN2 expression is a molecular feature of COPD-associated LUAD and counteracts LUAD development <i>in vivo</i> by maintaining anti-tumor immunity.

Abstrct_CN: <b>ç†è®ºä¾æ®ï¼š</ b>è‚ºè…ºç™Œï¼ˆLUADï¼‰çš„æ—©æœŸå‘ç—…æœºç†ä»ç„¶æœªçŸ¥ã€‚æˆ‘ä»¬å‘ç°ï¼Œä¸é‡ç”Ÿå‹åŒçªä»”ç›¸æ¯”ï¼Œå…·æœ‰æ°”é“è°±ç³»åŸºå› <i> Gprc5a </ i>çš„å°é¼ æ­£å¸¸æ°”é“ä¸­å›ºæœ‰å…ç–«è°ƒèŠ‚å‰‚lipocalin-2ï¼ˆ<i> Lcn2 </ i>ï¼‰ï¼ˆ <i> Gprc5a <sup>-/-</ sup> </ i>ï¼‰ï¼Œå¹¶ä¸”å®¹æ˜“äº§ç”Ÿç‚ç—‡å’ŒLUADã€‚ç„¶è€Œï¼Œäººä»¬å¯¹LCN2åœ¨è‚ºéƒ¨ç‚ç—‡å’ŒLUADä¸­çš„ä½œç”¨äº†è§£ç”šå°‘ã€‚ <b>ç›®æ ‡ï¼š</ b>æè¿°<i> Lcn2 </ i>è¯±å¯¼åœ¨LUADå‘ç—…ä¸­çš„ä½œç”¨ã€‚ <b>æ–¹æ³•ï¼š</ b>é€šè¿‡RNA-åˆ†æäº†æš´éœ²äºçƒŸè‰è‡´ç™Œç‰©ä¹‹å‰å’Œä¹‹åçš„<i> Gprc5a <sup>-/-</ sup> </ i>å°é¼ çš„æ­£å¸¸æ°”é“åˆ·ç‰™ï¼Œæœªç´¯åŠçš„è‚ºç»„ç»‡å’Œè‚¿ç˜¤ã€‚æ’åºã€‚åœ¨LUADï¼Œè‚ºé³ç™Œï¼ˆLUSCï¼‰ï¼Œæ…¢æ€§é˜»å¡æ€§è‚ºç—…ï¼ˆCOPDï¼‰å’ŒLUAD / LUSCåˆå¹¶COPDçš„å…¬å…±å’Œå†…éƒ¨æ•°æ®é›†ä¸­åˆ†æäº†<i> LCN2 </ i> mRNAã€‚åœ¨510ä¸ªè‚¿ç˜¤çš„ç»„ç»‡èŠ¯ç‰‡ä¸­å¯¹LCN2è›‹ç™½è¿›è¡Œäº†å…ç–«ç»„ç»‡åŒ–å­¦åˆ†æã€‚æ¯”è¾ƒ<i> Gprc5a <sup>-//-</ sup> </ i>å’Œ<i> Gprc5a <sup>-/-</ sup> / Lcn2ä¹‹é—´çš„æ—¶é—´æ€§è‚ºè‚¿ç˜¤å‘å±•ï¼ŒåŸºå› è¡¨è¾¾ç¨‹åºå’Œå®¿ä¸»å…ç–«ååº”<sup>-/-</ sup> </ i>åŒçªä»”ã€‚ <b>æµ‹é‡å’Œä¸»è¦ç»“æœï¼š</ b> <i> Lcn2 </ i>åœ¨LUADå‘è‚²è¿‡ç¨‹ä¸­é€æ¸å‡é«˜ï¼Œå¹¶ä¸”ä¸ä¿ƒç‚ç»†èƒå› å­å’Œç‚ç—‡åŸºå› é›†å‘ˆæ­£ç›¸å…³ã€‚ç›¸å¯¹äºæ­£å¸¸è‚ºï¼Œ<i> LCN2 </ i>åœ¨äººLUADä¸­æ˜æ˜¾å‡é«˜ï¼Œä½†åœ¨LUSCä¸­å´æ²¡æœ‰å‡é«˜ï¼Œå¹¶ä¸”ä¸å¸çƒŸè€…å’ŒLUADæ‚£è€…ä¸­çš„COPDç›¸å…³ã€‚ç›¸å¯¹äº<i> Gprc5a <sup>-/-</ sup> </ i>å°é¼ ï¼Œ<i> Gprc5a <sup>-// </ sup> / Lcn2 <sup>-/-</ sup> </åœ¨åŒçªå¹¼ä»”ä¸­ï¼Œè‚ºè‚¿ç˜¤çš„å‘å±•æ˜¾ç€å¢åŠ ï¼Œä¼´æœ‰Tç»†èƒä¸°åº¦ï¼ˆCD4 +ï¼‰å’Œä¸°å¯Œåº¦é™ä½ï¼ŒæŠ—è‚¿ç˜¤å…ç–«åŸºå› ç¨‹åºå‡å¼±ä»¥åŠå…ç–«ç»†èƒè¡¨è¾¾çš„ä¿ƒè‚¿ç˜¤ç‚æ€§ç»†èƒå› å­å¢åŠ ã€‚ <b>ç»“è®ºï¼š</ b>å¢å¼ºçš„LCN2è¡¨è¾¾æ˜¯ä¸COPDç›¸å…³çš„LUADçš„åˆ†å­ç‰¹å¾ï¼Œå¹¶é€šè¿‡ç»´æŒæŠ—è‚¿ç˜¤å…ç–«åŠ›æŠµæ¶ˆäº†LUADåœ¨ä½“å†…çš„å‘å±•ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32730595[0m

Title: Triplet-based similarity score for fully multi-labeled trees with poly-occurring labels.

Authors: Bernardini Giulia; Bonizzoni Paola; Ciccolella Simone; Denti Luca; Previtali Marco; Vedova Gianluca Della

Journal: Bioinformatics (Oxford, England) (Bioinformatics)

Date: 2020-Jul

Abstrct_EN: The latest advances in cancer sequencing, and the availability of a wide range of methods to infer the evolutionary history of tumors, have made it important to evaluate, reconcile and cluster different tumor phylogenies. Recently, several notions of distance or similarities have been proposed in the literature, but none of them has emerged as the golden standard. Moreover, none of the known similarity measures is able to manage mutations occurring multiple times in the tree, a circumstance often occurring in real cases. To overcome these limitations, in this paper we propose MP3, the first similarity measure for tumor phylogenies able to effectively manage cases where multiple mutations can occur at the same time and mutations can occur multiple times. Moreover, a comparison of MP3 with other measures shows that it is able to classify correctly similar and dissimilar trees, both on simulated and on real data. An open source implementation of MP3 is publicly available at https://github.com/AlgoLab/mp3treesim. Supplementary data are available at Bioinformatics online.

Abstrct_CN: ç™Œç—‡æµ‹åºçš„æœ€æ–°è¿›å±•ä»¥åŠæ¨æ–­è‚¿ç˜¤è¿›åŒ–å²çš„å¤šç§æ–¹æ³•çš„å¯ç”¨æ€§ï¼Œä½¿å¾—è¯„ä¼°ï¼Œè°ƒå’Œå’Œèšç±»ä¸åŒçš„è‚¿ç˜¤ç³»ç»Ÿå‘è‚²è‡³å…³é‡è¦ã€‚æœ€è¿‘ï¼Œæ–‡çŒ®ä¸­æå‡ºäº†å‡ ç§è·ç¦»æˆ–ç›¸ä¼¼æ€§çš„æ¦‚å¿µï¼Œä½†æ˜¯æ²¡æœ‰ä¸€ä¸ªæˆä¸ºé»„é‡‘æ ‡å‡†ã€‚æ­¤å¤–ï¼Œæ²¡æœ‰ä¸€ç§å·²çŸ¥çš„ç›¸ä¼¼æ€§åº¦é‡èƒ½å¤Ÿç®¡ç†åœ¨æ ‘ä¸­å¤šæ¬¡å‘ç”Ÿçš„çªå˜ï¼Œè¿™ç§æƒ…å†µç»å¸¸åœ¨å®é™…æƒ…å†µä¸‹å‘ç”Ÿã€‚ä¸ºäº†å…‹æœè¿™äº›å±€é™æ€§ï¼Œåœ¨æœ¬æ–‡ä¸­æˆ‘ä»¬æå‡ºäº†MP3ï¼Œè¿™æ˜¯ç”¨äºè‚¿ç˜¤ç³»ç»Ÿå‘ç”Ÿçš„ç¬¬ä¸€ä¸ªç›¸ä¼¼æ€§åº¦é‡ï¼Œèƒ½å¤Ÿæœ‰æ•ˆç®¡ç†å¯èƒ½åŒæ—¶å‘ç”Ÿå¤šä¸ªçªå˜å’Œå¤šæ¬¡çªå˜çš„æƒ…å†µã€‚æ­¤å¤–ï¼ŒMP3ä¸å…¶ä»–æªæ–½çš„æ¯”è¾ƒè¡¨æ˜ï¼Œå®ƒèƒ½å¤Ÿåœ¨æ¨¡æ‹Ÿæ•°æ®å’ŒçœŸå®æ•°æ®ä¸Šæ­£ç¡®åˆ†ç±»ç›¸ä¼¼å’Œä¸ç›¸ä¼¼çš„æ ‘ã€‚å¯åœ¨https://github.com/AlgoLab/mp3treesimä¸Šå…¬å¼€è·å¾—MP3çš„å¼€æºå®ç°ã€‚è¡¥å……æ•°æ®å¯ä»ç”Ÿç‰©ä¿¡æ¯å­¦åœ¨çº¿è·å¾—ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32730644[0m

Title: MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2.

Authors: Gao Yang; Guo Jing; Li Feng; Ni Jiali; Wei Lei; Xu Xiaolong; Yin Weinan; Yuan Xiaoning; Zhang Jingwei

Journal: Journal of cellular physiology (J. Cell. Physiol.)

Date: 2020-Jul

Abstrct_EN: Breast cancer is one of the most threatening diseases for women. Long noncoding RNAs were reported to be involved in breast cancer development. In this study, we analyzed The Cancer Genome Atlas breast cancer tissue high-throughput sequencing data and screened and validated the low-expressing long noncoding RNA named MAGI2-AS3. Through gene coexpression analysis, we found that MAGI2-AS3 has a good expression correlation with MAGI2. Overexpression of MAGI2-AS3 or MAGI2 in breast cancer cells MCF-7 would inhibit the Wnt/Î²-catenin pathway and inhibit cell proliferation and migration. Gene structure and DNA methylation analysis results indicated that MAGI2-AS3 may act as a cis-acting regulatory element downregulating the DNA methylation level of the MAGI2 promoter region, and the DNA demethylase TET1 inhibitor can reverse MAGI2-AS3 overexpression caused upregulation of MAGI2 and cellular effects. Our findings reveal the role of MAGI2-AS3 in breast cancer and provide potential novel therapeutic targets for metastatic breast cancer intervention.

Abstrct_CN: ä¹³è…ºç™Œæ˜¯å¥³æ€§æœ€å…·å¨èƒæ€§çš„ç–¾ç—…ä¹‹ä¸€ã€‚æ®æŠ¥é“ï¼Œé•¿çš„éç¼–ç RNAä¸ä¹³è…ºç™Œçš„å‘å±•æœ‰å…³ã€‚åœ¨è¿™é¡¹ç ”ç©¶ä¸­ï¼Œæˆ‘ä»¬åˆ†æäº†The Cancer Genome Atlasä¹³è…ºç™Œç»„ç»‡çš„é«˜é€šé‡æµ‹åºæ•°æ®ï¼Œå¹¶ç­›é€‰å¹¶éªŒè¯äº†ä½è¡¨è¾¾çš„é•¿éç¼–ç RNAï¼Œç§°ä¸ºMAGI2-AS3ã€‚é€šè¿‡åŸºå› å…±è¡¨è¾¾åˆ†æï¼Œæˆ‘ä»¬å‘ç°MAGI2-AS3ä¸MAGI2æœ‰è‰¯å¥½çš„è¡¨è¾¾ç›¸å…³æ€§ã€‚åœ¨ä¹³è…ºç™Œç»†èƒMCF-7ä¸­è¿‡è¡¨è¾¾MAGI2-AS3æˆ–MAGI2å°†æŠ‘åˆ¶Wnt /Î²-cateniné€šè·¯å¹¶æŠ‘åˆ¶ç»†èƒå¢æ®–å’Œè¿ç§»ã€‚åŸºå› ç»“æ„å’ŒDNAç”²åŸºåŒ–åˆ†æç»“æœè¡¨æ˜ï¼ŒMAGI2-AS3å¯èƒ½æ˜¯ä¸‹è°ƒMAGI2å¯åŠ¨å­åŒºåŸŸDNAç”²åŸºåŒ–æ°´å¹³çš„é¡ºå¼è°ƒæ§å…ƒä»¶ï¼ŒDNAè„±ç”²åŸºé…¶TET1æŠ‘åˆ¶å‰‚å¯ä»¥é€†è½¬MAGI2-AS3çš„è¿‡è¡¨è¾¾ï¼Œä»è€Œå¯¼è‡´MAGI2å’Œç»†èƒä¸Šè°ƒæ•ˆæœã€‚æˆ‘ä»¬çš„å‘ç°æ­ç¤ºäº†MAGI2-AS3åœ¨ä¹³è…ºç™Œä¸­çš„ä½œç”¨ï¼Œå¹¶ä¸ºè½¬ç§»æ€§ä¹³è…ºç™Œçš„å¹²é¢„æä¾›äº†æ½œåœ¨çš„æ–°å‹æ²»ç–—é¶æ ‡ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32730756[0m

Title: Outcomes of donor-derived superinfection screening in HIV-positive to HIV-positive kidney and liver transplantation: a multicentre, prospective, observational study.

Authors: Bonny Tania S; Brown Diane; Desai Niraj; Durand Christine M; Florman Sander; Friedman-Moraco Rachel J; Kirby Charles; Martens Craig; Petropoulos Christos; Redd Andrew D; Rose Rebecca; Segev Dorry L; Seisa Michael; Tobian Aaron A R; Turgeon Nicole A

Journal: The lancet. HIV (Lancet HIV)

Date: 2020-Jul

Abstrct_EN: One of the primary risks of HIV-positive to HIV-positive organ transplantation is loss of virological control because of donor-derived HIV superinfection, which occurs when an HIV-positive individual becomes infected with a new distinct HIV strain. In this study, as part of the larger HIV Organ Policy Equity pilot study, HIV-positive to HIV-positive kidney and liver transplant recipients in the USA were examined for evidence of sustained donor-derived HIV superinfection. In this multicentre, prospective, observational study, HIV-positive to HIV-positive kidney and liver transplant recipients were followed in three hospitals in the USA. Candidates with well controlled HIV infection on ART, no active opportunistic infections, and minimum CD4 T-cell counts (>100 cells per Î¼L for liver and >200 cells per Î¼L for kidney per federal guidelines) were eligible to receive a kidney or liver from deceased HIV-positive donors without active infections or neoplasm. Peripheral blood mononuclear cells were collected from donor-recipient pairs at the time of transplantation, and from recipients at several timepoints up to 3 years after transplantation. Donor samples were assessed for HIV RNA viral load, CD4 cell count, and antiretroviral drug-resistant mutations. Donor and recipient HIV proviral DNA, and viral RNA from the viraemic timepoint were sequenced using a site-directed next-generation sequencing assay for the reverse transcriptase and gp41 genes. Neighbour-joining phylogenetic trees and direct sequence comparison were used to detect the presence of HIV superinfection. This study is registered with ClinicalTrials.gov, NCT02602262. 14 HIV-positive to HIV-positive kidney and eight liver transplant recipients were followed from March, 2016, to July, 2019. 17 recipients had adequate viral sequences allowing for HIV superinfection assessment. Eight donors were suppressed (viral load <400 copies per mL), and none had multiclass drug-resistant mutations detected. None of the recipients examined had evidence of HIV superinfection. One recipient had a viraemic episode (viral load of 2â€ˆ080â€ˆ000 copies per mL) 3 years after transplantation as a result of non-adherence to ART. Only recipient viral sequences were detected during the viraemic episode, suggesting that the donor virus, if present, was not reactivated despite temporary withdrawal of ART. These findings suggest that loss of HIV suppression due to donor-derived HIV superinfection might not be a significant clinical concern in carefully monitored ART suppressed HIV-positive organ recipients. US National Institute of Allergy and Infectious Diseases and National Cancer Institute.

Abstrct_CN: HIVé˜³æ€§ç§»æ¤åˆ°HIVé˜³æ€§å™¨å®˜çš„ä¸»è¦é£é™©ä¹‹ä¸€æ˜¯ç”±äºä¾›ä½“è¡ç”Ÿçš„HIVè¿‡åº¦æ„ŸæŸ“è€Œå¯¼è‡´ç—…æ¯’å­¦æ§åˆ¶å¤±æ§ï¼Œè¿™æ˜¯åœ¨HIVé˜³æ€§ä¸ªä½“æ„ŸæŸ“æ–°çš„ç‹¬ç‰¹HIVæ ªæ—¶å‘ç”Ÿçš„ã€‚åœ¨è¿™é¡¹ç ”ç©¶ä¸­ï¼Œä½œä¸ºæ›´å¤§çš„HIVå™¨å®˜æ”¿ç­–å…¬å¹³æ€§è¯•ç‚¹ç ”ç©¶çš„ä¸€éƒ¨åˆ†ï¼Œæˆ‘ä»¬å¯¹ç¾å›½HIVé˜³æ€§çš„HIVé˜³æ€§è‚¾å’Œè‚ç§»æ¤æ¥å—è€…è¿›è¡Œäº†æ£€æŸ¥ï¼Œä»¥å¯»æ‰¾æŒç»­çš„ä¾›ä½“æ¥æºçš„HIVè¿‡åº¦æ„ŸæŸ“çš„è¯æ®ã€‚åœ¨è¿™é¡¹å¤šä¸­å¿ƒï¼Œå‰ç»æ€§ï¼Œè§‚å¯Ÿæ€§ç ”ç©¶ä¸­ï¼Œåœ¨ç¾å›½çš„ä¸‰å®¶åŒ»é™¢ä¸­è¿½è¸ªäº†HIVé˜³æ€§ä¸HIVé˜³æ€§çš„è‚¾è„å’Œè‚è„ç§»æ¤å—è€…çš„å…³ç³»ã€‚æ¥å—è¿‡ARTè‰¯å¥½æ§åˆ¶çš„HIVæ„ŸæŸ“ï¼Œæ— æ´»åŠ¨æ€§æœºä¼šæ„ŸæŸ“å’Œæœ€ä½CD4 Tç»†èƒè®¡æ•°ï¼ˆæ ¹æ®è”é‚¦æŒ‡å—ï¼Œè‚ç»†èƒ> 100ç»†èƒ/Î¼Lï¼Œè‚¾è„> 200ç»†èƒ/Î¼Lï¼‰çš„å€™é€‰äººæœ‰èµ„æ ¼æ¥å—æ¥è‡ªå·²æ­»çš„HIVé˜³æ€§ä¾›ä½“ï¼Œæ— æ´»åŠ¨æ„ŸæŸ“æˆ–è‚¿ç˜¤ã€‚åœ¨ç§»æ¤æ—¶ä»ä¾›ä½“-å—ä½“å¯¹ä¸­æ”¶é›†å¤–å‘¨è¡€å•æ ¸ç»†èƒï¼Œå¹¶åœ¨ç§»æ¤åé•¿è¾¾3å¹´çš„å‡ ä¸ªæ—¶é—´ç‚¹ä»å—ä½“ä¸­æ”¶é›†å¤–å‘¨è¡€ã€‚è¯„ä¼°æèµ è€…æ ·å“çš„HIV RNAç—…æ¯’è½½é‡ï¼ŒCD4ç»†èƒè®¡æ•°å’ŒæŠ—é€†è½¬å½•ç—…æ¯’è¯ç‰©è€è¯æ€§çªå˜ã€‚ä½¿ç”¨é€†è½¬å½•é…¶å’Œgp41åŸºå› çš„å®šç‚¹ä¸‹ä¸€ä»£æµ‹åºæµ‹å®šæ³•ï¼Œå¯¹æ¥è‡ªç—…æ¯’å­¦æ—¶é—´ç‚¹çš„ä¾›ä½“å’Œå—ä½“HIVåŸç—…æ¯’DNAä»¥åŠç—…æ¯’RNAè¿›è¡Œäº†æµ‹åºã€‚ç›¸é‚»çš„ç³»ç»Ÿå‘è‚²æ ‘å’Œç›´æ¥åºåˆ—æ¯”è¾ƒè¢«ç”¨æ¥æ£€æµ‹HIVè¿‡åº¦æ„ŸæŸ“çš„å­˜åœ¨ã€‚è¯¥ç ”ç©¶å·²åœ¨ClinicalTrials.govä¸Šæ³¨å†Œï¼ŒNCT02602262ã€‚ä»2016å¹´3æœˆåˆ°2019å¹´7æœˆï¼Œéšè®¿äº†14ä½HIVé˜³æ€§è‡³HIVé˜³æ€§è‚¾è„æ‚£è€…å’Œ8ä½è‚ç§»æ¤å—è€…ã€‚17ä½æ¥å—è€…çš„ç—…æ¯’åºåˆ—å……è¶³ï¼Œå¯ä»¥è¿›è¡ŒHIVè¿‡åº¦æ„ŸæŸ“è¯„ä¼°ã€‚å…«ä¸ªä¾›ä½“è¢«æŠ‘åˆ¶ï¼ˆç—…æ¯’è½½é‡<400æ‹·è´/ mLï¼‰ï¼Œå¹¶ä¸”æ²¡æœ‰ä¸€ä¸ªæ£€æµ‹åˆ°å¤šç±»è€è¯çªå˜ã€‚æ¥å—æ£€æŸ¥çš„æ¥å—è€…å‡æ— è‰¾æ»‹ç—…æ¯’è¶…æ„ŸæŸ“çš„è¯æ®ã€‚ä¸€ä½æ¥å—è€…ç”±äºä¸åšæŒæŠ—é€†è½¬å½•ç—…æ¯’æ²»ç–—ï¼Œåœ¨ç§»æ¤å3å¹´å‡ºç°ç—…æ¯’æ€§å‘ä½œï¼ˆæ¯æ¯«å‡ç—…æ¯’è½½é‡ä¸º2 080 000æ‹·è´ï¼‰ã€‚åœ¨ç—…æ¯’è¡€ç—‡å‘ä½œæœŸé—´ä»…æ£€æµ‹åˆ°å—ä½“ç—…æ¯’åºåˆ—ï¼Œè¿™è¡¨æ˜å°½ç®¡æš‚æ—¶åœç”¨äº†ARTï¼Œä½†ä¾›ä½“ç—…æ¯’ï¼ˆå¦‚æœå­˜åœ¨ï¼‰å¹¶æœªè¢«é‡æ–°æ¿€æ´»ã€‚è¿™äº›å‘ç°è¡¨æ˜ï¼Œåœ¨ç»è¿‡ä»”ç»†ç›‘æµ‹çš„ARTæŠ‘åˆ¶HIVé˜³æ€§å™¨å®˜æ¥å—è€…ä¸­ï¼Œç”±äºä¾›ä½“è¡ç”Ÿçš„HIVè¿‡åº¦æ„ŸæŸ“å¯¼è‡´çš„HIVæŠ‘åˆ¶ä¸§å¤±å¯èƒ½ä¸æ˜¯é‡è¦çš„ä¸´åºŠå…³æ³¨ç‚¹ã€‚ç¾å›½å›½å®¶è¿‡æ•å’Œä¼ æŸ“ç—…ç ”ç©¶æ‰€å’Œç¾å›½å›½å®¶ç™Œç—‡ç ”ç©¶æ‰€ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32730808[0m

Title: Multiple Signaling Roles of CD3Îµ and Its Application in CAR-T Cell Therapy.

Authors: Gao Shuaixin; He Xing; Huang Min; Hui Enfu; Jing Ruirui; Li Hua; Masubuchi Takeya; Meng Li; Shi Xiaoshan; Sun Jie; Wang Haopeng; Wong Catherine Chiulan; Wu Wei; Xu Chenqi; Xu Xinyi; Zhang Nan; Zhou Qiuping; Zhu Hengyu

Journal: Cell (Cell)

Date: 2020-Jul

Abstrct_EN: A TÂ cell receptor (TCR) mediates antigen-induced signaling through its associated CD3Îµ, Î´, Î³, and Î¶, but the contributions of different CD3 chains remain elusive. Using quantitative mass spectrometry, we simultaneously quantitated the phosphorylation of the immunoreceptor tyrosine-based activation motif (ITAM) of all CD3 chains upon TCR stimulation. A subpopulation of CD3Îµ ITAMs was mono-phosphorylated, owing to Lck kinase selectivity, and specifically recruited the inhibitory Csk kinase to attenuate TCR signaling, suggesting that TCR is a self-restrained signaling machinery containing both activating and inhibitory motifs. Moreover, we found that incorporation of the CD3Îµ cytoplasmic domain into a second-generation chimeric antigen receptor (CAR) improved antitumor activity of CAR-T cells. Mechanistically, the Csk-recruiting ITAM of CD3Îµ reduced CAR-T cytokine production whereas the basic residue rich sequence (BRS) of CD3Îµ promoted CAR-T persistence via p85 recruitment. Collectively, CD3Îµ is a built-in multifunctional signal tuner, and increasing CD3 diversity represents a strategy to design next-generation CAR.

Abstrct_CN: Tç»†èƒå—ä½“ï¼ˆTCRï¼‰é€šè¿‡ä¸å…¶ç›¸å…³çš„CD3Îµï¼ŒÎ´ï¼ŒÎ³å’ŒÎ¶ä»‹å¯¼æŠ—åŸè¯±å¯¼çš„ä¿¡å·ä¼ å¯¼ï¼Œä½†ä¸åŒçš„CD3é“¾çš„è´¡çŒ®ä»ç„¶éš¾ä»¥æ‰æ‘¸ã€‚ä½¿ç”¨å®šé‡è´¨è°±æ³•ï¼Œæˆ‘ä»¬åŒæ—¶å®šé‡äº†TCRåˆºæ¿€åæ‰€æœ‰CD3é“¾çš„å…ç–«å—ä½“åŸºäºé…ªæ°¨é…¸çš„æ´»åŒ–åŸºåºï¼ˆITAMï¼‰çš„ç£·é…¸åŒ–ã€‚ç”±äºLckæ¿€é…¶çš„é€‰æ‹©æ€§ï¼ŒCD3ÎµITAMçš„äºšç¾¤è¢«å•ç£·é…¸åŒ–ï¼Œå¹¶ä¸“é—¨å‹Ÿé›†äº†æŠ‘åˆ¶æ€§Cskæ¿€é…¶æ¥å‡å¼±TCRä¿¡å·ä¼ å¯¼ï¼Œè¿™è¡¨æ˜TCRæ˜¯ä¸€ç§è‡ªæˆ‘æŠ‘åˆ¶çš„ä¿¡å·ä¼ å¯¼æœºåˆ¶ï¼Œæ—¢åŒ…å«æ¿€æ´»åŸºå…ƒåˆåŒ…å«æŠ‘åˆ¶åŸºå…ƒã€‚æ­¤å¤–ï¼Œæˆ‘ä»¬å‘ç°å°†CD3Îµèƒè´¨åŸŸæ•´åˆåˆ°ç¬¬äºŒä»£åµŒåˆæŠ—åŸå—ä½“ï¼ˆCARï¼‰ä¸­å¯æ”¹å–„CAR-Tç»†èƒçš„æŠ—è‚¿ç˜¤æ´»æ€§ã€‚ä»æœºåˆ¶ä¸Šè®²ï¼ŒCD3Îµçš„Cskè¯±å¯¼ITAMå‡å°‘äº†CAR-Tç»†èƒå› å­çš„äº§ç”Ÿï¼Œè€ŒCD3Îµçš„åŸºæœ¬æ®‹åŸºå¯Œé›†åºåˆ—ï¼ˆBRSï¼‰é€šè¿‡å‹Ÿé›†p85ä¿ƒè¿›äº†CAR-TæŒä¹…æ€§ã€‚æ€»çš„æ¥è¯´ï¼ŒCD3Îµæ˜¯å†…ç½®çš„å¤šåŠŸèƒ½ä¿¡å·è°ƒè°å™¨ï¼Œè€Œä¸æ–­å¢åŠ çš„CD3å¤šæ ·æ€§åˆ™ä»£è¡¨äº†è®¾è®¡ä¸‹ä¸€ä»£CARçš„ç­–ç•¥ã€‚

[1m[33m####################################################################################################[0m

